Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2016-11-11 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Notice of AGM
Regulatory Filings Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 0295P' and 'This information is provided by RNS'). The core content states that copies of the '2016 Annual Report and Notice of the 2016 Annual General Meeting have been posted to shareholders.' Since the document is short (2334 chars) and its primary function is to announce the publication and availability of other documents (Annual Report and AGM Notice), it fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('MENU VS MEAL' rule). While it mentions the AGM, the document itself is the announcement, not the AGM materials (AGM-R) or the full Annual Report (10-K). RPA is the most precise classification for an announcement about the release of reports.
2016-11-11 English
Preliminary Results for the year end 30 June 2016
Earnings Release Classification · 1% confidence The document explicitly states it contains 'Preliminary Results for the year ended 30 June 2016 (unaudited)'. It provides detailed financial highlights (turnover, operating loss, cash reserves) and operational highlights for the fiscal year. This content structure is characteristic of an annual financial report summary. However, the document is released via 'RNS Number : 1705M' and is titled 'Preliminary Results', which often precedes the full 10-K filing or serves as the primary release of annual figures in the UK market. Given the comprehensive nature of the financial summary and the annual period covered, it aligns best with the Annual Report category (10-K) if it were the final audited version, or an Interim Report (IR) if it were semi-annual. Since it covers the full year and presents the core financial performance summary, and considering the context of UK reporting where preliminary results are the main annual announcement before the final audited accounts, it is classified as an Annual Report (10-K) or potentially an Earnings Release (ER) if it were just highlights. Because it contains detailed financial tables and operational reviews typical of a full annual review, '10-K' is the closest fit for a comprehensive annual performance document, although 'ER' (Earnings Release) is also plausible for preliminary results. Given the depth, I lean towards the comprehensive annual filing type. However, the presence of the RNS number and the term 'Preliminary' suggests it might be an announcement *of* the results rather than the full statutory report. If it were a short announcement linking to the full report, it would be RPA/RNS. Since the text provided is substantial and contains the core results narrative, it functions as the primary annual disclosure. In the context of the provided definitions, '10-K' is for the 'Official yearly report covering company activity and full financial performance.' This document serves that function for the year ended June 30, 2016. If the document were significantly shorter and only announced the release of this report, it would be RPA. Since it contains the results themselves, 10-K is the most appropriate classification for the content type, even if the release mechanism is RNS. FY 2016
2016-10-11 English
Notice of Preliminary Results
Regulatory Filings Classification · 1% confidence The document explicitly states it is an 'RNS Number' and the title is 'Notice of Preliminary Results'. It announces that the company 'will release its preliminary results for the twelve months ending 30 June 2016 on 11 October, 2016.' This is not the full results document itself (which would likely be an ER or IR, depending on the context, but since it's preliminary annual results, it's often an ER or MDA), but rather an announcement about *when* the results will be released. Furthermore, the document ends with 'This information is provided by RNS' and includes an RNS number. According to Rule 2, if a document is short and announces the publication of a report, it should be classified as a Report Publication Announcement (RPA). Since this is an announcement about the release date of preliminary results, RPA is the most appropriate classification, as it is announcing the publication event rather than containing the full results or management discussion.
2016-09-21 English
Appointment of Chief Financial Officer
Board/Management Information Classification · 1% confidence The document is explicitly marked with "RNS Number : 3852K" and contains the header "RNS". The content announces a change in the company's board of directors (appointment of CFO and standing down of Financial Director). This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the primary subject matter is management change, making MANG the most specific classification. The document length (5277 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2016-09-21 English
Trading Update
Earnings Release Classification · 1% confidence The document is identified by the RNS Number and the header 'RNS Number : 9178F' and 'RNS For release: 02 August 2016'. It announces key financial highlights for the full year ended 30 June 2016 (Revenue, EBITDA losses, Net cash) and mentions that audited full-year results will be announced later ('The Company expects to announce audited full year results in October 2016'). This structure—a brief announcement of preliminary financial performance metrics for a period—fits the definition of an Earnings Release (ER). Although it mentions the upcoming audited results (which would be 10-K), this document itself is the preliminary announcement of the period's performance. FY 2016
2016-08-02 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document explicitly starts with an 'RNS Number' and contains the header 'RNS Number : 7537F'. The content announces the 'Total Voting Rights' of the company as required by the FCA's Disclosure and Transparency Rule 5.6.1, providing the denominator for shareholder notification calculations. This is a standard regulatory announcement disseminated via the London Stock Exchange's news service (RNS). While it relates to share capital, it is not a formal share issue/change (SHA) or a transaction in own shares (POS), but rather a mandatory disclosure of the current total share count. Since it is a general regulatory announcement disseminated via RNS and doesn't fit a more specific category like DVA (voting results) or DIRS (insider trades), the most appropriate classification is the general regulatory filing category.
2016-07-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.